Syringes Industry Evolution, Puncture Precision, And Injecting Innovation

 

 

Global syringes industry databook is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

The global syringes industy size was valued at USD 43.98 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.02% from 2023 to 2030.

 

Access the Global Syringes Industry Data Book, 2023 to 2030, Compiled Report By Grand View Research

 

Prefilled Syringes Market Report Highlights

The global prefilled syringes market generated over USD 20.61 billion revenue in 2022 and is projected to expand at a CAGR of around 11.94% during the forecast period.

 

• In terms of revenue, the disposable prefilled syringes segment accounted for the largest market share of 78.98% in 2021. This is owing to a high preference for patient safety, which has led to a rise in the use of disposable prefilled syringes in hospitals and home care settings.

• The glass syringes segment dominated the market with around 53.27% of the revenue share in 2021, because most glass prefilled syringes may administer highly viscous drugs along with can be utilized across a wide range of therapeutic areas, such as vaccines, blood therapeutic proteins, and stimulants.
• Diabetessegment captured the largest market share with around 53.75% in 2021. Increasing prevalence of diabetes globally along with the government initiatives.
• The hospitals segment captured the largest market share with around 52.39% in 2021. The growth of this segment can mainly be attributed to increasing in the number of patients suffering from various chronic ailments and the consequent rise in surgical procedures.
• Asia Pacific was the fastest-growing market for prefilled syringes with a growth rate of 12.96%, owing to the increasing patient population and rapid adoption of prefilled syringes in this region.
• Prominent key players present in the prefilled syringes market are Gerresheimer AG, Schott Group, BD, Unilife Corporation, Nipro Medical Corporation, Owen Mumford, and Haselmeier AG.

 

Disposable Syringes Market Report Highlights

The global disposable syringes market size was valued at USD 14.19 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.21% from 2023 to 2030.

 

• The conventional syringes segment accounted for the largest share of around 53% in 2022. The use of injection and auto-injectors comprises the use of needles. Conventional syringes are the most practiced and used syringes in homecare settings. For instance, B.D.’s conventional syringes and needles range, the conventional disposable syringes guarantee protection for the patient receiving it. Such factors are likely to drive segment growth
• The safety syringes segment is estimated to register the fastest CAGR of 6.4% from 2023 to 2030. Safety syringes are required for most diagnostic and therapeutic approaches for chronic diseases since they are essential during medication administration and tests, resulting in rising product demand. In 2019, Japanese firm Morimoto Pharma launched a S.A.F.E. Syringe Kit vial comprising pre-attached needle syringes and a tube-shaped container into an innovative synergistic design. Such innovations are expected to ease product usage for healthcare workers
• The hospital end-use segment accounted for the largest revenue share of over 50% in 2022 due to studies being meticulously designed to maximize the chances of detecting meaningful treatment. The demand for dispensing syringes in hospitals continues to rise. Prefilled and disposable syringes are becoming increasingly common in some European states due to the use of prefilled syringes in ICUs and operating theaters

 

Order your copy of the Free Sample of “Syringes Industry Data Book - Prefilled Syringes, Disposable Syringes, Dental and Micro Syringes Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Dental Syringes Market Report Highlights

The dental syringes market was valued at USD 8.95 billion in 2022. High demand for specially designed syringes for dentistry is expected to fuel the market growth over the compounded annual growth rate of 5.05% from 2023 to 2030.

 

• Based on product, the reusable syringes segment accounted for the largest market share of around 53.0% in 2022 due to its use in the administration of anesthesia and the increasing prevalence of dental diseases
• Based on end-use, the hospitals segment dominated the market with a share of 51.9% due to their easy accessibility
• The outpatient facilities segment is expected to grow at the fastest CAGR of 5.5% over the forecast period owing to their cost effectiveness
• North America dominated the market with a share of 34.5% in 2022. This growth can be attributed to the increasing proportion of geriatric population and increasing awareness among people regarding oral health

 

Micro Syringes Market Report Highlights

The micro syringes market was valued at USD 0.23 billion in 2022. High demand for specially designed syringes for dentistry is expected to fuel the market growth over the compounded annual growth rate of 6.4% from 2023 to 2030.

 

• Based on syringe type, the autosampler syringes segment accounted for the largest revenue share of over 60.0% in 2022, and is expected to grow at the fastest CAGR of 6.4% over the forecast period. Due to the growing acceptance of precision autosamplers, the market is growing
• Based on end-use, the hospitals segment accounted for the largest revenue share of around 47.0% in 2022. Different types of micro syringes are frequently needed in hospitals to accommodate various medical specializations, including diagnostics, anesthesia, and oncology
• The outpatient facilities segment is expected to grow at the fastest CAGR of 6.5% over the forecast period. The growing tendency toward ambulatory services and outpatient care is in line with the flexibility and convenience of outpatient facilities
• North America dominated the market with a revenue share of over 40.0% due to the rising prevalence of chronic illnesses and advancements in healthcare technologies. Asia Pacific is anticipated to grow at the fastest CAGR of 7.6% over the forecast period with countries such as China and India serving as significant centers for pharmaceutical production and research

 

Go through the table of content of Syringes Industry Data Book to get a better understanding of the Coverage & Scope of the study. 

Syringes Industry Data Book Competitive Landscape

Market players in the syringe market undertake several organic and in-organic growth strategies in order to strengthen their product portfolios and offer diverse technologically advanced and innovative products to their customers. These strategies are prominently adopted by companies to attract more customers in the market.

 

Key players operating in the Syringes industry are –

• Nipro Corporation
• Medtronic
• Baxter International, Inc.
• B.Braun Melsungen AG
• Dentsply Sirona
• Integra LifeSciences Corporation
• Agilent Technologies
• Hamilton Company
• B Braun Melsungen AG
• PerkinElmer, Inc.
• Unilife Corporation
• SCHOTT
• 3M
• Gerresheimer AG

Magnetic Resonance Imaging Scanners And Accessories Industry: Innovation And A Global Scan

  

 

Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Covers Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market.

 

Global magnetic resonance imaging scanners and accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

Access the Global Magnetic Resonance Imaging Scanners and Accessories Industry Data Book, 2023 to 2030, Compiled Report By Grand View Research

 

Magnetic Resonance Imaging Market Report Highlights

The global magnetic resonance imaging (MRI) market size was valued at USD 5.26 billion in 2022 and is anticipated to grow at a CAGR of 7.1% over the forecast period.

 

• The adoption of advanced imaging technologies is augmenting the growth of the global market
• The open system segment is anticipated to be the fastest-growing segment during the forecast period due to its efficiency in accommodating all sizes of patients without feeling claustrophobic
• MRI for neurological and brain disorders dominated the market due to the growing number of neurological conditions and increasing demand for less invasive diagnostic procedures
• The high-field MRI segment is expected to experience the fastest growth rate due to its efficiency in providing detailed images for diagnosis
• Imaging centers are expected to exhibit the highest growth rate during the forecast period. Government initiatives to improve primary care are one of the major factors impacting the segment growth
• In 2023, North America dominated the global market with the largest revenue share owing to continuous research and adoption of advanced techniques in the region
• Asia Pacific is anticipated to grow at the fastest growth rate from 2024 to 2030 due to the growing number of clinical studies in the region for high-field MRI machines

 

 

MRI Coils Market Report Highlights

The global magnetic resonance imaging coils market size was valued at USD 7.99 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2023 to 2030.

 

• Based on type, radiofrequency coil segments accounted for the largest market share of 59.5% in 2022. It is also anticipated to grow at the fastest CAGR of 8.9 % over the forecast period.

• Based on application, the neurology segment accounted for the largest market share of 22.6% in 2022 and the segment is also expected to witness the fastest CAGR of 8.9%.

• Based on end-use, the hospital segment accounted for the highest revenue share and the ambulatory care center segment is expected to grow with the fastest CAGR of 9.1%.

 

Motion Tracking Systems Market Report Highlights

The global MRI motion tracking systems market size was valued at USD 2.76 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 20.8% from 2023 to 2030. 

 

• Optical Tracking Systems like cameras are largely adopted by MRI manufacturers due to their increased efficacy and image capture accuracy

• The marker systems segment is expected to grow at a lucrative CAGR in the global market during the forecast period

• The North America region dominated with a revenue share of 58.38% in 2021 and is expected to grow at a CAGR of over 20% from 2022 to 2030

 

Order your copy of the Free Sample of “Magnetic Resonance Imaging Scanners and Accessories Industry Data Book - Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Competitive Landscape

 

The high price is one of the most impeding factors for the sales of these systems. The major players are focusing on minimizing the prices for medium-strength MRI systems using various methods. Technological advancements in manufacturing and the high influx of these systems in the market is expected to bring the prices down in the upcoming years. 

Key players operating in the Magnetic Resonance Imaging Scanners and Accessories Industry are –

• GE Healthcare
• Siemens Healthineers
• Toshiba Corporation
• Aurora Imaging Technologies, Inc.
• Koninklijke Philips N.V.
• Esaote SPA
• Sanrad Medical Systems Pvt ltd
• Fujifilm
• MR Instruments, Inc.
• RAPID MR International, LLC
• ScanMed
• Canon Medical Systems Corporation
• Hologic Inc.
• Bruker
• TracInnovations
• Kineticor
• Metria Innovations

Neurodegenerative Disease Therapeutics Industry Future And Journey Of Decoding The Cure

  

 

Neurodegenerative Disease Therapeutics Industry Data Book Covers Parkinson’s Disease Treatment and Alzheimer's Therapeutics Market. The global neurodegenerative disease industry combine to account for USD 8.33 billion revenue in 2021, which is expected to reach USD 28.15 billion by 2030, growing at a cumulative rate of 15.6% over the forecast period.

 

Global neurodegenerative disease therapeutics industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.

 

Access the Global Neurodegenerative Disease Therapeutics Industry Data Book, 2023 to 2030, Compiled Report By Grand View Research

 

 

Parkinson’s Disease Treatment Market Insights

The global Parkinson’s disease treatment market size was valued at USD 4.28 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030.

 

Parkinson’s Disease Treatment Market Report Highlights

• By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment
• The retail pharmacy distribution channel segment dominated the global industry in 2021
• This is due to the easy availability of PD drugs in well-established retail pharmacy chains including Walgreens and Walmart
• Asia Pacific is expected to be the fastest-growing region during the forecast period due to the entry of new products into the market
• In June 2020, Ono Pharmaceutical Co., Ltd. received manufacturing and marketing approval for Ongentys to treat patients with PD in Japan

 

Alzheimer's Therapeutics Market Report Highlights

• By product, the cholinesterase inhibitors segment held the largest revenue share in 2022 as it is the current standard of care. In March 2022, the U.S. FDA approved the cholinesterase inhibitor Adlarity (donepezil hydrochloride) developed by Corium Inc. for the treatment of patients with AD
• Pipeline drugs are anticipated to witness the fastest growth over the forecast period due to the presence of a strong product pipeline and their expected launch during the forecast period. Biogen’s product lecanemab (BAN2401), an anti-amyloid beta protofibril antibody for treating AD, is currently in phase 3 clinical trials
• The hospital pharmacy end-user segment dominated the market in 2022 owing to the high hospitalization rate. According to Alzheimer’s Association report 2022, approximately 32% of total Medicare beneficiaries with Alzheimer’s have at least one hospital discharge annually

 

Order your copy of the Free Sample of “Neurodegenerative Disease Therapeutics Industry Data Book - Parkinson’s Disease Treatment and Alzheimer's Therapeutics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research 

 

 

Neurodegenerative Disease Therapeutics Industry Data Book Competitive Landscape

Competitive rivalry in this market is likely to be high due to increasing number of mergers, acquisitions, and partnerships undertaken by major players globally. Many established and clinical-stage pharmaceutical companies are involved in the development of novel therapies & drugs to target people with unmet clinical needs.

 

Key players operating in the Neurodegenerative Disease Therapeutics industry are –

• Eisai Co., Ltd.
• AbbVie Inc. (Allergan Plc.)
• Merck & Co., Inc.
• Adamas Pharmaceuticals, Inc.
• Novartis AG,H. Lundbeck A/S
• Cerevel Therapeutics
• Biogen
• Daiichi Sankyo Company, Limited
• F. Hoffmann La Roche Ltd.
• TauRx Pharmaceuticals Ltd.
• Johnson & Johnson Services, Inc.
• AC Immune
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc. (GSK). 

Healthcare 3D Printing Industry Promises Of Biofabrication For A Healthier Tomorrow

 

 

Global healthcare 3D printing industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. 

 

The healthcare 3D printing industry was valued at USD 9.4 billion in 2022 and is estimated to witness a CAGR of 17.0% over the forecast period. 

 

Healthcare Additive Manufacturing Market Growth & Trends

 

The global healthcare additive manufacturing market size was estimated at USD 7.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 18.1% from 2023 to 2030. The growing demand for customized medical and dental additives, including personalized implants, medical models, orthodontic appliances, splints, dental models, and others, is expected to drive the market's growth over the forecast period. 

 

In healthcare, the requirement of every patient is unique, which has led to the high potential of additive manufacturing for customized and personalized medical applications. Moreover, the rising initiatives by the organization and the government to support small and medium-sized companies are expected to propel growth. For instance, in May 2022, U.S. President Joe Biden launched Additive Manufacturing Forward by joining five leading manufacturers in the U.S. to aid small-sized suppliers based in the U.S. to increase the utilization of additive manufacturing.

 

3D Bioprinting Market Growth & Trends

 

The global 3D bioprinting market size was valued at USD 2.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.48% from 2023 to 2030. The market is driven by the global organ donation shortage and utilization and demand for 3D Bioprinting to reduce animal testing of chemical, cosmetic, and pharmaceutical products. According to the organdonor.gov by the Health Resources and Services Administration, as of January 2023, around 104,234 individuals in the U.S. were waiting for organ transplantation list in the U.S. and around 88,901 individuals among them were waiting for kidney transplantation. Moreover, 3D Bioprinting is increasingly used as an alternative to animal experimentation in biomedical research. For instance, in February 2022, Bioprinting by light-sheet lithography: engineering of complex tissues with high resolution at a high-speed project (BRIGHTER Project) collaborated with the Institute of Bioengineering of Catalonia (IBEC) in the development of technology for the production of functional human tissues to replace animal testing.

 

3D Printed Drugs Market Growth & Trends 

 

The global 3D printed drugs market size was valued at USD 86.2 million in 2022 and is expected to expand at a CAGR of 14.78% from 2023 to 2030. The rising demand for personalized medicine and the growing adoption of R&D activities for the adoption of 3D printing in drug manufacturing is expected to drive the market growth during the forecast period. 3D printed drugs can manufacture tailored dosages and significantly reduce the cost of the products; hence, many pharmaceutical corporations are adopting this technology to innovate the products. For instance, in February 2020, Merck collaborated with AMCM to develop and produce GMP tablet formulation by 3D printing technology for clinical trials and commercial manufacturing services.

 

Order your copy of Free Sample of “Healthcare 3D Printing Industry Data Book - Healthcare Additive Manufacturing, 3D Bioprinting and 3D Printed Drugs Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Competitive Landscape

 

Key players operating in the Healthcare 3D Printing Industry are –

• 3D Systems, Inc.
• EnvisionTEC
• Stratasys Ltd.
• Allevi, Inc.
• GE Healthcare
• Nanoscribe GmbH
• Materialise N.V.
• Cyfuse Biomedical
• RegenHU
• Renishaw

Female Infertility Industry Helps In Cracking The Fertile Code: Innovation And Advancements

 

 

Global female infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.

 

 

The global female infertility market size was valued at USD 25.7 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.97% from 2023 to 2030.

 

In Vitro Fertilization Market Growth & Trends

 

The global In-Vitro Fertilization (IVF) market size was valued at USD 23.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.72% from 2023 to 2030. This can be attributed to higher success rates and the introduction of advanced technologies, such as Percutaneous Epidydimal Sperm Aspiration and Testicular Sperm Extraction (PESA & TESE), three-parent IVF, mini-IVF, and others. Moreover, an increase in government funding for IVF is expected to boost segment growth over the forecast period. For instance, in May 2022, in Australia, under NSW Government 2022-23 budget, women in New South Wales opting for IVF will be provided with a USD 2,000 cash rebate to reduce the costs of the treatment for patients.

 

Fertility clinics and hospitals are key end-use segments analyzed in this study. Fertility clinics accounted for the maximum share of the market in 2022 and will continue to dominate the market during the forecast period, being the most preferred setting for physicians and surgeons. Licensed fertility clinics offer counseling to couples facing problems in conceiving. Based on the severity of their problems, doctors and specialists plan their IVF treatment. The IVF treatments offered by hospitals are generally more expensive than fertility clinics. IVF treatments require highly skilled physicians and staff. Hence, employing dedicated staff for IVF in hospitals is a less preferable approach. 

 

Artificial Insemination Market Growth & Trends

 

The global artificial insemination market is valued at USD 2.1 billion as of 2022 and is expected to expand at a CAGR of 8.58% for the forecast period 2023-2030. This can be majorly attributed to the demand for minor fertility treatments and lower costs of treatment compared to IVF. Intrauterine insemination is the preferable treatment among all types of artificial insemination procedures. The intrauterine mode of insemination involves placing the sperm sample directly in the uterus and yields higher pregnancy rates. It is a non-invasive technique and is preferred by most of the infertile couples.

 

The market’s growth is driven by the lower cost of treatment, which is more suitable for minor fertility conditions and same-sex couples or single women. As per Human Fertilization and Embryology Authority (HFEA), the success rate of artificial insemination per cycle ranges from 15.8% for women under 35 to 11% for women aged 35 to 39, and 4.7% for women aged 40 to 42. Over the first six cycles, more than half of the women who had IUI reported pregnancy.

 

IUI is preferred over other methods as it is noninvasive, affordable, can be easily performed, there are minimum risks involved, and is easy to train. The pregnancy rate by IUI is higher than that by other modes of insemination. 

 

Order your copy of Free Sample of “Female Infertility Industry Data Book - In Vitro Fertilization (IVF) and Artificial Insemination Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research 

 

Competitive Landscape

Key players operating in the Female Infertility Industry are –

• Ferring B.V.
• Vitrolife AB
• CooperSurgical, Inc.
• Cosmos Biomedical Ltd.
• Merck KGaA
• Cryolab Ltd.
• FUJIFILM Irvine Scientific
• Bloom IVF Centre
• Microm UK Ltd.
• OvaScience
• Irvine Scientific
• Progyny, Inc.
• EMD Serono Inc.
• Thermo Fisher Scientific Inc.
• Boston IVF

Cancer Diagnostics Industry | Cutting-Edge Technologies Revolution

Global cancer diagnostics industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. 

The global cancer diagnostics market is combined to account for USD 45.66 billion revenue in 2022, which is expected to reach USD 89.02 billion by 2030, growing at a cumulative rate of 5.97% over the forecast period. 

 

Breast Cancer Diagnostics Market Growth & Trends

 

The global breast cancer diagnostics market size was valued at USD 16.26 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.24% from 2023 to 2030. The growth can be attributed to the increasing prevalence of cancer and rising government initiatives to increase the screening and diagnostic rate. Increased R&D in advanced breast cancer screening tools is anticipated to boost the market significantly.

 

The UK Research and Innovation, in February 2020, received over USD 1300 million from the Engineering and Physical Sciences Research Council to develop a novel Raman spectroscopy platform for noninvasive and in vivo diagnostics of breast cancer. The approach would allow immediate and accurate diagnosis in conjunction with mammography by improving surveillance or screening techniques that would lead to better treatment outcomes & early diagnosis. Moreover, increased product launch is anticipated to boost market growth over the forecast period. In February 2023, NGeneBio launched an NGS-based breast cancer diagnostics test in Thailand. Moreover, in October 2022, NAMIDA LAB announced plans to launch Auria, an at-home breast assessment test. Thus, an increase in such initiatives undertaken by market players is expected to propel the adoption of breast cancer diagnostic tests in the near future. 

 

Cervical Cancer Diagnostic Market Growth & Trends

 

The global cervical cancer diagnostic market was valued at USD 4.55 billion in 2022 and is projected to grow at a CAGR of 5.65% over the forecast period. Women between the age group of 20 and 60 years are usually more prone to this ailment, which is expected to increase cervical cancer screening and diagnostics procedures. 

 

New approvals and product launches due to high investments by market players are likely to boost the market. In November 2021, Hologic, Inc. announced the Genius Digital Diagnostics System launch and made it commercially available in Europe. This innovative NGS system combines advanced volumetric imaging technology with AI. In March 2023, Roche entered into a partnership with CAPED for the launch of a cervical cancer screening program in India to enhance and promote cancer care globally. The increase in the use of novel products by major market players for various cervical screening programs is expected to boost the market during the forecast period. 

Lung Cancer Diagnostics Market Growth & Trends

 

The global lung cancer diagnostics market size was estimated at USD 10.82 billion in 2022. Technological advancements in tumor diagnosis contribute to market growth. An increase in the availability of various technologically advanced products for cancer diagnostics is a major factor anticipated to fuel the market during the forecast period. Companies such as Oncocyte offer DetermaDx, a multigene assay that can help measure gene expression in circulating blood cells to identify lung nodules, avoiding invasive biopsy procedures. In January 2020, Oncocyte acquired Insight Genetics to develop a PCR-based Immune Modulation (IM) Score Test. The test is expected to help measure the state of the immune system during a biopsy procedure and identify patient response to PD-1/PD-L1 immunotherapies. 

 

Similarly, in March 2023, Roche Diagnostics Korea announced the launch of uPath PD-L1, an automated AI tool used to detect PD-L1 biomarkers in NSCLC patients. Moreover, in June 2022, Biocartis received a CE marking for Idylla GeneFusion Panel, which is an IVD-based lung cancer screening solution for laboratories. Such innovative product launches are anticipated to drive the market growth over the forecast period. 

 

Order your copy of Free Sample of “Cancer Diagnostics Industry Data Book - Breast Cancer Diagnostic, Cervical Cancer Diagnostic, Lung Cancer Diagnostic, Liver Cancer Diagnostic, Pancreatic Cancer Diagnostic and Ovarian Cancer Diagnostic Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Pancreatic Cancer Diagnostic Market Growth & Trends

 

The global pancreatic cancer diagnostic market size was valued at USD 3.63 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.43% from 2023 to 2030. Several key factors are driving the global market for pancreatic cancer diagnostics. Factors include the increasing prevalence of pancreatic cancer and a growing awareness of the importance of early disease diagnosis. Additionally, advancements in technology have led to improved accuracy and sensitivity of diagnostic tests and the evolution of molecular diagnostics and biomarker tests for detecting malignancies. These factors collectively propel the market demand for pancreatic cancer diagnostic solutions.

 

Early diagnosis plays a crucial role in achieving positive treatment outcomes for pancreatic cancer. Consequently, market players and healthcare organizations are actively raising funds, conducting awareness programs, and initiating research initiatives to promote routine checkups and screenings. For example, in August 2022, the Pancreatic Cancer Action Network (PanCAN) awarded USD 10.5 million in grants to support 16 new research and development projects focused on early detection and improved treatment options for pancreatic cancer.

Ovarian Cancer Diagnostics Market Growth & Trends

 

The global ovarian cancer diagnostics market size was estimated at USD 4.41 billion in 2022 and is expected to grow at a CAGR of 4.93% during the forecast period. An increase in the number of R&D activities to develop novel diagnostic tests for ovarian cancer is expected to propel the market. For instance, scientists from the University of Gothenburg and Uppsala University developed a blood test that can provide precise diagnostics for ovarian cancer, which could eliminate the requirement for exploratory surgery. This novel test can decrease the requirement for surgery and aid in the early detection and treatment of affected women. 

 

In February 2020, a study conducted by two hospitals in Australia focused on women with advanced ovarian cancer. It used an immune marker for inflammation and other cancer markers to detect epithelial ovarian cancer. The test can be used by women staying in remote areas or disadvantaged communities, where there are limited resources for diagnosis of ovarian cancer, thus improving their chances of survival. The blood test is used to measure a body’s immune response to enhance the diagnosis of ovarian cancer. 

Liver Cancer Diagnostics Market Growth & Trends

 

The global liver cancer diagnostics market size was valued at USD 5.99 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.96% by 2030. Liver cancer is a significant contributor to cancer-related deaths worldwide. According to the American Cancer Society, the incidence of liver cancer has tripled in the last three decades, with death rates also doubling. In 2022, it was approximately 41,260 new cases of liver cancer will be diagnosed in the U.S., resulting in approximately 30,520 deaths. The global prevalence of liver cancer, combined with the continuous exposure of the population to risk factors, will drive the rapid growth of the screening and diagnosis market. 

 

Various risk factors contribute to the development of liver cancer, including lifestyle choices such as smoking, alcohol consumption, and tobacco chewing, as well as underlying conditions like chronic viral hepatitis (hepatitis B virus or hepatitis C virus), cirrhosis, type 2 diabetes, and obesity. The presence of one or more risk factors increases the likelihood of liver cancer. Accurate early detection, diagnosis, and staging are crucial for improving survival rates. 

  

Key players operating in the Cancer Diagnostics Industry are –

• GE Healthcare
• Abbott
• F. Hoffmann-La Roche Ltd.,
• QIAGEN
• BD
• Siemens Healthcare GmbH,
• Thermo Fisher Scientific; Inc.
• Hologic, Inc.
• Koninklijke Philips N.V. (Philips)
• IIumina, inc.

Livestock Artificial Insemination Industry | Breeding Brilliance and Cutting Edge of Livestock AI

 

 

Global livestock artificial insemination industry data book is a collection of market sizing information & forecasts, regulatory data, competitive benchmarking analyses, macro-environmental analyses, and technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

The global livestock artificial insemination market size was estimated at USD 6.45 billion in 2022 and is anticipated to increase at a CAGR of 6.30% from 2023 to 2030.

 

Bovine Artificial Insemination Market Growth & Trends

 

The global bovine artificial insemination market size was valued USD 2.84 billion in 2022, registering a CAGR of 6.17% over the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the growth include the increasing uptake of artificial insemination solutions, technological advancements, demand for meat, milk, and dairy products, and supportive initiatives by the private & public sectors. In 2022, for instance, ABS Global - the bovine genetics division of Genus plc, reported a revenue of USD 340.64 million with an estimated 3% increase in volumes of bovine semen and embryo. The company also reported an 18% increase in volumes of sexed semen for its Sexcel and IntelliGen portfolios.

 

Equine Artificial Insemination Market Growth & Trends

The global equine artificial insemination market size was valued USD 0.64 billion in 2022, expanding at a CAGR of 5.80% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of artificial insemination (AI) in horses, awareness about the benefits of AI, and demand to increase animal productivity are some of the key factors propelling the market growth. For instance, AI eliminates the risks associated with handling aggressive stallions, reducing the chances of injuries to both horses and handlers. It also enables breeders to manage and monitor mare fertility more effectively. By controlling the timing of insemination and monitoring the mare's reproductive cycle, breeders can optimize the chances of successful conception. Furthermore, AI facilitates breeders to access stallions located in different parts of the world without the need for transporting the animals physically. This opens up opportunities for international and long-distance breeding, facilitating the exchange of genetic material across borders. These factors are expected to fuel the market growth in the coming years.

 

Swine Artificial Insemination Market Growth & Trends

The global swine artificial insemination market size was valued USD 1.91 billion in 2022, expanding at a CAGR of 6.67% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is characterized by initiatives by key companies, demand for sustainable food production, consumption of pork, and growing uptake of artificial insemination in swine. Semen Cardona S.L. one of the key players in the market reported that the company was exploring opportunities in emerging markets such as Mexico, Colombia, and the Philippines. In the year 2022 alone, the company distributed more than 0.7 million semen doses in Mexico with scope for further growth. Similar initiatives are propelling market growth. Moreover, the increasing consumption of pork is anticipated to contribute to the demand for AI services to ensure production safety, sustainability, and efficiency. Consumption of pork meat is expected to increase from 112.58 megatons to 127.27 megatons from 2022 to 2029 according to estimates by OECD. 

 

Order your copy of Free Sample of “Livestock Artificial Insemination Industry Data Book - Bovine, Equine, Swine, Ovine & Caprine Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Ovine And Caprine Artificial Insemination Market Growth & Trends

The global ovine and caprine artificial insemination market size was valued USD 1.06 billion in 2022, expanding at 6.25% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Drivers contributing to the market growth include increasing access to buck (a male goat) and ram (a male sheep) semen, improved reproductive efficiency by adopting artificial insemination, and demand for genetic improvement in the sheep and goat industries. Artificial insemination allows farmers and breeders to access high-quality genetics from superior male animals. By using AI, they can introduce desired traits such as improved meat quality, milk production, disease resistance, and reproductive performance into their herds or flocks. As technology continues to advance and demand for quality genetics grows, the market is expected to expand further during the forecast period. 

Key players operating in the Livestock Artificial Insemination Industry are –

• Genus Plc
• SEMEX
• URUS Group
• STgenetics
• Munster Bovine
• Stallion AI Services
• MINITÜB GMBH
• IMV Technologies
• B&D Genetics
• SEK Genetics
• Semen Cardona S.L.
• Swine Genetics International